MentionFox
Home › 5%+ stakes › Manufacturing (industry group 38), latest filing in October 2026
5%+ stakes

Manufacturing (industry group 38), latest filing in October 2026

15 companies with 5%+ holders, every filing linked: 3m Company, Axogen, Inc., Bioventus Inc., Garmin Ltd, Globus Medical Inc, Illumina Inc and more. Each section is the company's full record from its filings, newest filings first within each section.

On this page

3m Company

At 5% or more3
Filings11
Latest filing2026-10-16

3m Company has 11 Schedule 13D or 13G filings on record since 2025-07-30. 3 holders' latest filing reports 5% or more of common stock, par value $.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Jpmorgan Chase & Co.8.5%44,111,814SCHEDULE 13G/A, 2026-10-162026-09-30
Vanguard Capital Management7.56%39,527,316SCHEDULE 13G, 2026-04-272026-03-31
BlackRock, Inc.6.6%34,291,537SCHEDULE 13G/A, 2026-04-272026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Jpmorgan Chase & Co.40,221,356590,95843,971,302135,928SCHEDULE 13G/A, 2026-10-16

The latest filing identifies 3m Company by CUSIP 88579Y101 and gives its principal executive office as 3M Center, St. Paul, MN 55144-1000 (SCHEDULE 13G/A, 2026-10-16).

FiledHolderPercentFiling
2025-07-30Jpmorgan Chase & Co.7.6%SCHEDULE 13G
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-27BlackRock, Inc.6.6%SCHEDULE 13G/A
2026-04-27Vanguard Capital Management7.56%SCHEDULE 13G
2026-05-04Jpmorgan Chase & Co.8.8%SCHEDULE 13G/A
2026-05-08Jpmorgan Chase & Co.8.8%SCHEDULE 13G/A
2026-05-11Jpmorgan Chase & Co.8.8%SCHEDULE 13G/A
2026-05-11Jpmorgan Chase & Co.8.8%SCHEDULE 13G/A
2026-05-12Jpmorgan Chase & Co8.8%SCHEDULE 13G/A
2026-07-27Jpmorgan Chase & Co.7.4%SCHEDULE 13G/A
2026-10-16Jpmorgan Chase & Co.8.5%SCHEDULE 13G/A

Axogen, Inc.

At 5% or more2
Filings7
Latest filing2026-10-02

Axogen, Inc. has 7 Schedule 13D or 13G filings on record since 2025-11-14. 2 holders' latest filing reports 5% or more of common stock, $0.01 par value. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Mathew P. Arens7.58%4,072,910SCHEDULE 13G/A, 2026-08-142026-06-30
Divisadero Street Capital Management, LP6.8%3,983,783SCHEDULE 13G, 2026-10-022026-10-02
Vanguard Capital Management4.99%2,654,445SCHEDULE 13G/A, 2026-07-312026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
First Light Asset Management, LLC03,746,38003,746,380SCHEDULE 13G/A, 2026-08-14
Mathew P. Arens187,0003,885,910187,0003,885,910SCHEDULE 13G/A, 2026-08-14
Divisadero Street Capital Management, LP03,983,78303,983,783SCHEDULE 13G, 2026-10-02
William Zolezzi03,983,78303,983,783SCHEDULE 13G, 2026-10-02
Divisadero Street Partners, L.P.03,436,00803,436,008SCHEDULE 13G, 2026-10-02
Divisadero Street Partners GP, LLC03,436,00803,436,008SCHEDULE 13G, 2026-10-02
Divisadero Street Capital, LLC03,983,78303,983,783SCHEDULE 13G, 2026-10-02
Vanguard Capital Management396,49702,654,4450SCHEDULE 13G/A, 2026-07-31

The latest filing identifies Axogen, Inc. by CUSIP 05463X106 and gives its principal executive office as 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL 32615 (SCHEDULE 13G, 2026-10-02).

FiledHolderPercentFiling
2025-11-14Mathew P. Arens12.88%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management5.12%SCHEDULE 13G
2026-05-07Mathew P. Arens6.8%SCHEDULE 13G/A
2026-07-31Vanguard Capital Management4.99%SCHEDULE 13G/A
2026-08-14Mathew P. Arens7.58%SCHEDULE 13G/A
2026-10-02Divisadero Street Capital Management, LP6.8%SCHEDULE 13G

Bioventus Inc.

At 5% or more1
Filings4
Latest filing2026-10-27

Bioventus Inc. has 4 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of class a stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Nantahala Capital Management, LLC9.03%6,047,403SCHEDULE 13G/A, 2026-02-132025-12-31
BlackRock, Inc.4.9%3,365,612SCHEDULE 13G/A, 2026-10-272026-09-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Nantahala Capital Management, LLC06,047,40306,047,403SCHEDULE 13G/A, 2026-02-13
Wilmot B. Harkey06,047,40306,047,403SCHEDULE 13G/A, 2026-02-13
Daniel Mack06,047,40306,047,403SCHEDULE 13G/A, 2026-02-13
BlackRock, Inc.3,299,80203,365,6120SCHEDULE 13G/A, 2026-10-27

The latest filing identifies Bioventus Inc. by CUSIP 09075A108 and gives its principal executive office as 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC 27703 (SCHEDULE 13G/A, 2026-10-27).

FiledHolderPercentFiling
2025-08-14Nantahala Capital Management, LLC7.96%SCHEDULE 13G/A
2026-02-13Nantahala Capital Management, LLC9.03%SCHEDULE 13G/A
2026-07-27BlackRock, Inc.5.02%SCHEDULE 13G
2026-10-27BlackRock, Inc.4.9%SCHEDULE 13G/A

Garmin Ltd

At 5% or more2
Filings12
Latest filing2026-10-13

Garmin Ltd has 12 Schedule 13D or 13G filings on record since 2025-07-07. 2 holders' latest filing reports 5% or more of registered shares. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Kao Min H9.7%18,662,265SCHEDULE 13G/A, 2026-10-132026-09-30
Vanguard Capital Management6.36%12,244,166SCHEDULE 13G, 2026-04-282026-03-31
Burrell Jonathan4.85%9,355,009SCHEDULE 13G/A, 2026-07-092026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Kao Min H018,662,265018,662,265SCHEDULE 13G/A, 2026-10-13
Kao Yu-Fan C018,662,265018,662,265SCHEDULE 13G/A, 2026-10-13
Vanguard Capital Management1,621,010012,244,1660SCHEDULE 13G, 2026-04-28
Burrell Jonathan7,440,7091,914,3007,440,7091,914,300SCHEDULE 13G/A, 2026-07-09

The latest filing identifies Garmin Ltd by CUSIP H2906T109 and gives its principal executive office as MUHLENTALSTRASSE 36/38, SCHAFFHAUSEN (SCHEDULE 13G/A, 2026-10-13).

FiledHolderPercentFiling
2025-07-07The Vanguard Group10.23%SCHEDULE 13G/A
2025-07-14Jonathan Burrell5.07%SCHEDULE 13G/A
2025-10-02Kao Min H9.7%SCHEDULE 13G/A
2025-10-24Burrell Jonathan5.08%SCHEDULE 13G/A
2026-01-14Burrell Jonathan5%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-15Burrell Jonathan5.02%SCHEDULE 13G/A
2026-04-15Kao Min H9.7%SCHEDULE 13G/A
2026-04-28Vanguard Capital Management6.36%SCHEDULE 13G
2026-07-09Burrell Jonathan4.85%SCHEDULE 13G/A
2026-07-10Kao Min H9.7%SCHEDULE 13G/A
2026-10-13Kao Min H9.7%SCHEDULE 13G/A

Globus Medical Inc

At 5% or more1
Filings4
Latest filing2026-10-30

Globus Medical Inc has 4 Schedule 13D or 13G filings on record since 2026-03-26. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.8%10,704,283SCHEDULE 13G/A, 2026-10-272026-09-30
Vanguard Capital Management4.43%5,960,866SCHEDULE 13G/A, 2026-10-302026-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.10,335,190010,704,2830SCHEDULE 13G/A, 2026-10-27
Vanguard Capital Management885,30705,960,8660SCHEDULE 13G/A, 2026-10-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Globus Medical Inc by CUSIP 379577208 and gives its principal executive office as 2560 General Armistead Avenue, Audubon, PA 19403 (SCHEDULE 13G/A, 2026-10-30).

FiledHolderPercentFiling
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management5.22%SCHEDULE 13G
2026-10-27BlackRock, Inc.8%SCHEDULE 13G/A
2026-10-30Vanguard Capital Management4.43%SCHEDULE 13G/A

Illumina Inc

At 5% or more4
Filings8
Latest filing2026-10-30

Illumina Inc has 8 Schedule 13D or 13G filings on record since 2025-08-13. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Fmr LLC10.7%16,169,439SCHEDULE 13G, 2026-10-072026-09-30
Capital World Investors10.3%15,776,452SCHEDULE 13G/A, 2026-05-142026-03-31
BlackRock, Inc.8.9%13,479,370SCHEDULE 13G/A, 2026-10-272026-09-30
Vanguard Capital Management7.58%11,448,726SCHEDULE 13G/A, 2026-10-302026-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Fmr LLC15,355,487016,169,4390SCHEDULE 13G, 2026-10-07
Abigail P. Johnson0016,169,4390SCHEDULE 13G, 2026-10-07
Capital World Investors15,688,387015,776,4520SCHEDULE 13G/A, 2026-05-14
BlackRock, Inc.11,956,205013,479,3700SCHEDULE 13G/A, 2026-10-27
Vanguard Capital Management1,562,249011,448,7260SCHEDULE 13G/A, 2026-10-30

The latest filing identifies Illumina Inc by CUSIP 452327109 and gives its principal executive office as 5200 Illumina Way, San Diego, CA 92122 (SCHEDULE 13G/A, 2026-10-30).

FiledHolderPercentFiling
2025-08-13Capital World Investors10.7%SCHEDULE 13G/A
2025-11-13Capital World Investors13.2%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management5.19%SCHEDULE 13G
2026-05-14Capital World Investors10.3%SCHEDULE 13G/A
2026-10-07Fmr LLC10.7%SCHEDULE 13G
2026-10-27BlackRock, Inc.8.9%SCHEDULE 13G/A
2026-10-30Vanguard Capital Management7.58%SCHEDULE 13G/A

Insulet Corporation

At 5% or more2
Filings9
Latest filing2026-10-27

Insulet Corporation has 9 Schedule 13D or 13G filings on record since 2025-08-13. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.7.7%5,337,778SCHEDULE 13G/A, 2026-10-272026-09-30
Vanguard Capital Management7.49%5,277,842SCHEDULE 13G, 2026-04-302026-03-31
Capital Research Global Investors2.4%1,669,556SCHEDULE 13G/A, 2026-05-142026-03-31
Fmr LLC1.4%964,297SCHEDULE 13G/A, 2026-08-062026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.5,091,51005,337,7780SCHEDULE 13G/A, 2026-10-27
Capital Research Global Investors1,664,27401,669,5560SCHEDULE 13G/A, 2026-05-14
Fmr LLC692,9860964,2970SCHEDULE 13G/A, 2026-08-06
Abigail P. Johnson00964,2970SCHEDULE 13G/A, 2026-08-06

The latest filing identifies Insulet Corporation by CUSIP 45784P101 and gives its principal executive office as 100 NAGOG PARK, ACTON, MA 01720 (SCHEDULE 13G/A, 2026-10-27).

FiledHolderPercentFiling
2025-08-13Capital Research Global Investors6.7%SCHEDULE 13G/A
2025-10-30The Vanguard Group12.49%SCHEDULE 13G/A
2026-02-05Fmr LLC9%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.49%SCHEDULE 13G
2026-05-06Fmr LLC5.6%SCHEDULE 13G/A
2026-05-14Capital Research Global Investors2.4%SCHEDULE 13G/A
2026-08-06Fmr LLC1.4%SCHEDULE 13G/A
2026-10-27BlackRock, Inc.7.7%SCHEDULE 13G/A
DateRecordFigureOur pageSource
September 16, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
September 10, 2026Leadership change: Timothy J. Scannell departs, Director—Leadership changesSource
June 25, 2026Leadership change: Jonathan J. Mazelsky appointed, Director—Leadership changesSource

MiniMed Group, Inc.

At 5% or more1
Filings3
Latest filing2026-10-22

MiniMed Group, Inc. has 3 Schedule 13D or 13G filings on record since 2026-05-06. 1 holder's latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Capital Ventures International7.8%21,911,680SCHEDULE 13G, 2026-10-222026-10-15
Medtronic plc0%0SCHEDULE 13G/A, 2026-10-162026-10-15
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Capital Ventures International6,394,13621,911,6806,394,13621,911,680SCHEDULE 13G, 2026-10-22
Susquehanna Advisors Group, Inc.021,911,680021,911,680SCHEDULE 13G, 2026-10-22
Susquehanna Fundamental Investments, LLC1,76421,911,6801,76421,911,680SCHEDULE 13G, 2026-10-22
Susquehanna Portfolio Strategies, LLC970,89221,911,680970,89221,911,680SCHEDULE 13G, 2026-10-22
Susquehanna Securities, LLC14,544,88821,911,68014,544,88821,911,680SCHEDULE 13G, 2026-10-22
Medtronic plc0000SCHEDULE 13G/A, 2026-10-16

The latest filing identifies MiniMed Group, Inc. by CUSIP 60365F109 and gives its principal executive office as 18000 Devonshire St., Northridge, CA 91325 (SCHEDULE 13G, 2026-10-22).

FiledHolderPercentFiling
2026-05-06Medtronic plc90%SCHEDULE 13G
2026-10-16Medtronic plc0%SCHEDULE 13G/A
2026-10-22Capital Ventures International7.8%SCHEDULE 13G
DateRecordFigureOur pageSource
October 16, 2026Leadership change: Amy Bricker appointed, Director—Leadership changesSource
August 5, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
June 29, 2026Leadership change: David Endicott appointed, Director, and 1 more—Leadership changesSource
May 18, 2026Leadership change: Brett Wall departs, Director, and 1 more—Leadership changesSource
March 6, 2026IPO filing, Form 424B4$20 a shareIPO filingsSource
February 27, 2026IPO filing, Form S-1/A—IPO filingsSource
February 24, 2026IPO filing, Form S-1/A—IPO filingsSource
January 23, 2026IPO filing, Form S-1/A—IPO filingsSource
December 19, 2025IPO filing, Form S-1—IPO filingsSource

Movado Group, Inc.

At 5% or more2
Filings7
Latest filing2026-10-21

Movado Group, Inc. has 7 Schedule 13D or 13G filings on record since 2025-10-15. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Dimensional Fund Advisors LP5.5%861,123SCHEDULE 13G/A, 2026-01-212025-12-31
Goldman Sachs Asset Management, L.P.5.4%850,626SCHEDULE 13G, 2025-11-132025-09-30
Royce & Associates LP4.71%752,000SCHEDULE 13G/A, 2026-10-212026-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Dimensional Fund Advisors LP843,3950861,1230SCHEDULE 13G/A, 2026-01-21
Royce & Associates LP752,0000752,0000SCHEDULE 13G/A, 2026-10-21
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Movado Group, Inc. by CUSIP 624580106 and gives its principal executive office as V.P. Corporate Communications, 650 From Road, Paramus, NJ 7652 (SCHEDULE 13G/A, 2026-10-21).

FiledHolderPercentFiling
2025-10-15Royce & Associates LP7.9%SCHEDULE 13G/A
2025-11-13Goldman Sachs Asset Management, L.P.5.4%SCHEDULE 13G
2026-01-20Royce & Associates LP6.71%SCHEDULE 13G/A
2026-01-21Dimensional Fund Advisors LP5.5%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-07-22Royce & Associates LP5.24%SCHEDULE 13G/A
2026-10-21Royce & Associates LP4.71%SCHEDULE 13G/A

Pulsenmore Ltd.

At 5% or more2
Filings2
Latest filing2026-10-08

Pulsenmore Ltd. has 2 Schedule 13D or 13G filings on record since 2026-04-28. 2 holders' latest filing reports 5% or more of ordinary shares, par value nis 0.00032 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Elazar Sonnenschein28.79%1,872,092SCHEDULE 13G, 2026-04-282026-03-31
Aquamarine Financial (Cayman) Ltd5.02%338,541SCHEDULE 13G, 2026-10-082026-03-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Elazar Sonnenschein1,872,09201,872,0920SCHEDULE 13G, 2026-04-28
Aquamarine Financial (Cayman) Ltd338,5410338,5410SCHEDULE 13G, 2026-10-08

The latest filing identifies Pulsenmore Ltd. by CUSIP M8S7C5117 and gives its principal executive office as 8 Omarim St, Omer (SCHEDULE 13G, 2026-10-08).

FiledHolderPercentFiling
2026-04-28Elazar Sonnenschein28.79%SCHEDULE 13G
2026-10-08Aquamarine Financial (Cayman) Ltd5.02%SCHEDULE 13G
DateRecordFigureOur pageSource
July 7, 2026Form D, private offering$7.50M soldForm D pageSource

Revvity Inc

At 5% or more5
Filings13
Latest filing2026-10-07

Revvity Inc has 13 Schedule 13D or 13G filings on record since 2025-08-14. 5 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
T. Rowe Price Associates, Inc.11.8%13,204,725SCHEDULE 13G/A, 2026-10-072026-09-30
T. Rowe Price Investment Management, Inc.9.2%10,261,343SCHEDULE 13G/A, 2026-09-082026-08-31
Vanguard Capital Management7.44%8,326,862SCHEDULE 13G, 2026-04-302026-03-31
EdgePoint Investment Group Inc.7.39%8,574,280SCHEDULE 13G/A, 2025-11-142025-09-30
Janus Henderson Group Plc6.6%7,627,259SCHEDULE 13G/A, 2025-11-142025-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
T. Rowe Price Associates, Inc.12,884,429013,204,7250SCHEDULE 13G/A, 2026-10-07
T. Rowe Price Investment Management, Inc.9,612,201010,261,3430SCHEDULE 13G/A, 2026-09-08

The latest filing identifies Revvity Inc by CUSIP 714046109 and gives its principal executive office as 940 WINTER STREET, WALTHAM, MA 02451 (SCHEDULE 13G/A, 2026-10-07).

FiledHolderPercentFiling
2025-08-14T. Rowe Price Associates, Inc.6.8%SCHEDULE 13G/A
2025-08-14EdgePoint Investment Group Inc.5.76%SCHEDULE 13G
2025-08-14Janus Henderson Group Plc6.1%SCHEDULE 13G
2025-11-14EdgePoint Investment Group Inc.7.39%SCHEDULE 13G/A
2025-11-14Janus Henderson Group Plc6.6%SCHEDULE 13G/A
2026-02-17T. Rowe Price Investment Management, Inc.19.8%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-30Vanguard Capital Management7.44%SCHEDULE 13G
2026-05-15T. Rowe Price Associates, Inc.9%SCHEDULE 13G/A
2026-08-14T. Rowe Price Associates, Inc.5%SCHEDULE 13G/A
2026-08-14T. Rowe Price Investment Management, Inc.16.4%SCHEDULE 13G/A
2026-09-08T. Rowe Price Investment Management, Inc.9.2%SCHEDULE 13G/A
2026-10-07T. Rowe Price Associates, Inc.11.8%SCHEDULE 13G/A

Senseonics Holdings, Inc.

At 5% or more3
Filings4
Latest filing2026-10-27

Senseonics Holdings, Inc. has 4 Schedule 13D or 13G filings on record since 2025-08-08. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Sessa Capital IM, L.P.9.9%12,437,532SCHEDULE 13G, 2026-08-142026-06-30
Robert J. Smith6.14%50,035,000SCHEDULE 13G/A, 2025-08-082025-05-19
BlackRock, Inc.5.2%2,743,263SCHEDULE 13G/A, 2026-10-272026-09-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Sessa Capital IM, L.P.012,437,532012,437,532SCHEDULE 13G, 2026-08-14
John Petry012,437,532012,437,532SCHEDULE 13G, 2026-08-14
Robert J. Smith50,035,000050,035,0000SCHEDULE 13G/A, 2025-08-08
Energy Capital, LLC49,700,000049,700,0000SCHEDULE 13G/A, 2025-08-08
Plato & Associates, LLC335,0000335,0000SCHEDULE 13G/A, 2025-08-08
BlackRock, Inc.2,702,54802,743,2630SCHEDULE 13G/A, 2026-10-27

The latest filing identifies Senseonics Holdings, Inc. by CUSIP 81727U303 and gives its principal executive office as 20451 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876 (SCHEDULE 13G/A, 2026-10-27).

FiledHolderPercentFiling
2025-08-08Robert J. Smith6.14%SCHEDULE 13G/A
2026-07-30BlackRock, Inc.6.6%SCHEDULE 13G
2026-08-14Sessa Capital IM, L.P.9.9%SCHEDULE 13G
2026-10-27BlackRock, Inc.5.2%SCHEDULE 13G/A
DateRecordFigureOur pageSource
May 29, 2025Form D, private offering$20.27M soldForm D pageSource

Trimble Inc

At 5% or more5
Filings9
Latest filing2026-10-27

Trimble Inc has 9 Schedule 13D or 13G filings on record since 2025-08-05. 5 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Vanguard Capital Management7.57%17,729,466SCHEDULE 13G, 2026-04-302026-03-31
BlackRock, Inc.6.7%15,623,632SCHEDULE 13G/A, 2026-10-272026-09-30
Ameriprise Financial, Inc.5.4%12,681,912SCHEDULE 13G, 2026-08-142026-06-30
Vanguard Portfolio Management5.33%12,485,111SCHEDULE 13G, 2026-04-292026-03-31
State Street Corporation5%11,656,926SCHEDULE 13G, 2026-08-072026-06-30
Morgan Stanley4.1%9,570,627SCHEDULE 13G/A, 2026-05-122026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.14,751,842015,623,6320SCHEDULE 13G/A, 2026-10-27
Ameriprise Financial, Inc.011,559,588012,681,912SCHEDULE 13G, 2026-08-14
State Street Corporation07,279,877011,644,706SCHEDULE 13G, 2026-08-07
Morgan Stanley08,253,03109,269,461SCHEDULE 13G/A, 2026-05-12

The latest filing identifies Trimble Inc by CUSIP 896239100 and gives its principal executive office as 10368 WESTMOOR DR, WESTMINSTER, CO 80021 (SCHEDULE 13G/A, 2026-10-27).

FiledHolderPercentFiling
2025-08-05Morgan Stanley5.5%SCHEDULE 13G
2026-01-30The Vanguard Group12.84%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management5.33%SCHEDULE 13G
2026-04-30Vanguard Capital Management7.57%SCHEDULE 13G
2026-05-12Morgan Stanley4.1%SCHEDULE 13G/A
2026-08-07State Street Corporation5%SCHEDULE 13G
2026-08-14Ameriprise Financial, Inc.5.4%SCHEDULE 13G
2026-10-27BlackRock, Inc.6.7%SCHEDULE 13G/A

UFP Technologies Inc

At 5% or more4
Filings7
Latest filing2026-10-09

UFP Technologies Inc has 7 Schedule 13D or 13G filings on record since 2026-02-06. 4 holders' latest filing reports 5% or more of common stock sh sh. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Wasatch Advisors LP7.1%552,809SCHEDULE 13G/A, 2026-10-092026-09-30
Neuberger Berman Group LLC6.9%537,038SCHEDULE 13G, 2026-07-072026-06-30
Congress Asset Management Co5.4%416,762SCHEDULE 13G, 2026-04-232026-03-31
Vanguard Capital Management5.01%387,783SCHEDULE 13G, 2026-07-312026-06-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Wasatch Advisors LP363,2920552,8090SCHEDULE 13G/A, 2026-10-09
Neuberger Berman Group LLC0509,4140537,038SCHEDULE 13G, 2026-07-07
Neuberger Berman Investment Advisers LLC0498,1650525,722SCHEDULE 13G, 2026-07-07
Vanguard Capital Management58,1600387,7830SCHEDULE 13G, 2026-07-31

The latest filing identifies UFP Technologies Inc by CUSIP 902673102 and gives its principal executive office as 100 Hale Street, Newburyport, MA 01950 (SCHEDULE 13G/A, 2026-10-09).

FiledHolderPercentFiling
2026-02-06Wasatch Advisors LP10.1%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-23Congress Asset Management Co5.4%SCHEDULE 13G
2026-07-07Neuberger Berman Group LLC6.9%SCHEDULE 13G
2026-07-17Wasatch Advisors LP8.8%SCHEDULE 13G/A
2026-07-31Vanguard Capital Management5.01%SCHEDULE 13G
2026-10-09Wasatch Advisors LP7.1%SCHEDULE 13G/A
DateRecordFigureOur pageSource
June 10, 2026Leadership change: Ryan Stafford appointed, General Counsel, and 2 more—Leadership changesSource
May 26, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Vontier Corp

At 5% or more4
Filings6
Latest filing2026-10-28

Vontier Corp has 6 Schedule 13D or 13G filings on record since 2025-11-05. 4 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Fmr LLC10.6%15,421,300SCHEDULE 13G/A, 2026-01-082025-12-31
Vanguard Portfolio Management6.52%9,234,080SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.24%7,431,753SCHEDULE 13G, 2026-04-302026-03-31
Franklin Templeton, Inc.5.1%6,844,155SCHEDULE 13G, 2026-10-282026-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Vanguard Portfolio Management24,40609,234,0800SCHEDULE 13G, 2026-04-29
Vanguard Capital Management1,086,93607,431,7530SCHEDULE 13G, 2026-04-30
Franklin Templeton, Inc.6,574,13730,1456,813,33030,825SCHEDULE 13G, 2026-10-28
Charles B. Johnson0000SCHEDULE 13G, 2026-10-28
Rupert H. Johnson, Jr.0000SCHEDULE 13G, 2026-10-28
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Vontier Corp by CUSIP 928881101 and gives its principal executive office as 5438 Wade Park Boulevard, Suite 600, Raleigh, NC 27607 (SCHEDULE 13G, 2026-10-28).

FiledHolderPercentFiling
2025-11-05Fmr LLC9.5%SCHEDULE 13G/A
2026-01-08Fmr LLC10.6%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management6.52%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.24%SCHEDULE 13G
2026-10-28Franklin Templeton, Inc.5.1%SCHEDULE 13G
DateRecordFigureOur pageSource
October 8, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All 5%+ stakes

RSS